Investment
Features
FeesSafety
Academy
More
Pluang+

BioVie to present Phase 2 trial results of bezisterim for Long COVID and Parkinson's at ANA2026

Market News
14 Oct 2026
Proactive Investors
View Source
Bullish
BioVie to present Phase 2 trial results of bezisterim for Long COVID and Parkinson's at ANA2026

BioVie Inc will present results from two Phase 2 trials of its experimental drug bezisterim for Long COVID and Parkinson's disease at the American Neurological Association meeting in San Diego from October 17 to 20. The trials showed promising improvements in inflammation markers, neuronal health, and symptoms such as brain fog, fatigue, and motor function. Bezisterim is an oral drug that crosses the blood-brain barrier and aims to reduce inflammation without suppressing the immune system. These results could advance treatment options for chronic neurological conditions and follow BioVie's ongoing research in Alzheimer's disease.

BioVie’s upcoming presentation on Long COVID and Parkinson’s trial results provides context for health sector activity. For readers following the health sector, here is Pluang's market snapshot as of Oct 14, 2026 20:11 WIB: out of 150 priced US health stocks, 73 rose and 68 fell. Notable movers include BNGO at USD 1.39 with a 1.84% gain and a typical hold time of 50 days, HIMS at USD 29.20 down 1.72%, and BKD at USD 10.29 up 1.63%.

More News

ASML reports strong Q3 2026 EPS of $14.65 on high chip equipment demand despite slight revenue miss.

ASML reports strong Q3 2026 EPS of $14.65 on high chip equipment demand despite slight revenue miss.

ASML Holding posted a strong Q3 2026 earnings per share of $14.65, beating estimates of $12.17, driven by a 55% year-over-year sales growth and a 57.5% gross margin. Although revenue was slightly below expectations at $13.05 billion, the company bene...

Company Fundamentals
Bullish
58 minutes ago
Charles Schwab Q3 earnings expected to rise on strong trading and asset management revenue.

Charles Schwab Q3 earnings expected to rise on strong trading and asset management revenue.

Charles Schwab is set to report its Q3 2026 earnings with an estimated EPS of $1.66 and revenue around $7.18-$7.19 billion, reflecting significant growth driven by an 18.2% increase in trading revenue, net interest income, and asset management fees. ...

Company Fundamentals
Bullish
1 hour ago
TSOs prioritize software investments to boost grid security and capacity amid rising demand

TSOs prioritize software investments to boost grid security and capacity amid rising demand

Transmission System Operators (TSOs) are increasingly investing in software like Energy Management Systems and grid planning tools to modernize aging infrastructure, enhance cybersecurity, and expand grid capacity. Cybersecurity remains their top con...

Market News
Neutral
1 hour ago
Air Canada launches nonstop Montreal-Seville flights starting September 2027, expanding its European network.

Air Canada launches nonstop Montreal-Seville flights starting September 2027, expanding its European network.

Air Canada will begin a new seasonal nonstop flight service between Montreal and Seville, Spain, starting September 8, 2027. This route is the only nonstop connection between North America and Seville, enhancing travel options for leisure and busines...

Market News
Bullish
1 hour ago
Air Canada to launch non-stop Montréal-Seville flights in Sept 2027, expanding its European network.

Air Canada to launch non-stop Montréal-Seville flights in Sept 2027, expanding its European network.

Air Canada announced it will start non-stop seasonal flights between Montréal and Seville, Spain, beginning September 8, 2027. This new route is the only direct connection between North America and Seville, enhancing travel options for Canadians and ...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App